p.61 抽出テキスト

Council on Cardiovascular Disease in the Young and Council on Cardiovascular and Stroke Nursing. Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association. Circulation 2019; 140: e234-e284 PMID: 31256636 91. Miller JR, Lancaster TS, Callahan C, et al. An overview of mechanical circulatory support in single-ventricle patients. Transl Pediatr 2018; 7: 151-161. PMID: 29770296 92. Morales DLS, Rossano JW, VanderPluym C, et al. Pedimacs Investigators. Third Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report: Preimplant Characteristics and Outcomes. Ann Thorac Surg 2019; 107: 993-1004. PMID: 30817920 93. Cedars A, Tecson KM, Zaidi AN, et al. Impact of durable ventricular assist device support on outcomes of patients with congenital heart disease waiting for heart transplant. ASAIO J 2020; 66: 513-519. PMID: 31335373 94. SRTR: Scientific Registry of Transplant Recipients. https://www.srtr. org/ [2018年11月11日閲覧] 95. Komagamine M, Nishinaka T, Ichihara Y, et al. Ventricular assist device implantation late after double switch operation for L-transposition of the great arteries. Ann Thorac Surg 2014; 98: e109-e111. PMID: 25441828 96. Tanoue Y, Fujino T, Tatewaki H, et al. Jarvik 2000 axial flow ventricular assist device in right single ventricle after Fontan operation. J Artif Organs 2019; 22: 338-340. PMID: 31392523 97. Tanoue Y, Jinzai Y, Tominaga R. Jarvik 2000 axial-flow ventricular assist device placement to a systemic morphologic right ventricle in congenitally corrected transposition of the great arteries. J Artif Organs 2016; 19: 97-99. PMID: 26341249 98. Carlo WF, Villa CR, Lal AK, et al. Ventricular assist device use in single ventricle congenital heart disease. Pediatr Transplant 2017; 21: e13031. PMID: 28921937 99. Chen S, Rosenthal DN, Murray J, et al. Bridge to transplant with ventricular assist device support in pediatric patients with single ventricle heart disease. ASAIO J 2020; 66: 205-211. PMID: 30864969 100. Buratto E, Shi WY, Ye XT, et al. Ventricular assist devices for the failing univentricular circulation. Expert Rev Med Devices 2017; 14: 449-459. PMID: 28532240 101. Villa CR, Morales DLS. The Total artificial heart in end-stage congenital heart disease. Front Physiol 2017; 8: 131. PMID: 28536530 102. Wells D, Villa CR, Simón Morales DL. The 50/50 cc total artificial heart trial: extending the benefits of the total artificial heart to underserved populations. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2017; 20: 16-19. PMID: 28007058 103. Lorts A, Villa C, Riggs KW, et al. First use of HeartMate 3 in a failing Fontan circulation. Ann Thorac Surg 2018; 106: e233-e234. PMID: 29752919 104. Granegger M, Thamsen B, Hubmann EJ, et al. A long-term mechanical cavopulmonary support device for patients with Fontan circulation. Med Eng Phys 2019; 70: 9-18. PMID: 31266678 105. Peura JL, Colvin-Adams M, Francis GS, et al. American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, et al. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation 2012; 126: 2648-2667. PMID: 23109468 106. Stevenson LW, Pagani FD, Young JB, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009; 28: 535-541. PMID: 19481012 107. 日本胸部外科学会.J-MACS Statistical Report(2010年6月-2019年6月).2019.http://www.jpats.org/uploads/uploads/files/J-MACS Statistical 20Report(2010年6月-2019年6月).pdf 107a. 日本循環器学会/日本心不全学会合同ガイドライン.2021年JCS/ JHFS ガイドラインフォーカスアップデート版 急性・慢性心不全診療.2021年.https://www.j-circ.or.jp/cms/wp-content/uploads/2021 /03/JCS2021_Tsutsui.pdf 108. Kormos RL, Cowger J, Pagani FD, et al. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships. Ann Thorac Surg 2019; 107: 341-353. PMID: 30691584 109. Cowger J, Shah P, Stulak J, et al. INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome. J Heart Lung Transplant 2016; 35: 440-448. PMID: 26683809 110. Estep JD, Starling RC, Horstmanshof DA, et al. ROADMAP Study Investigators. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP Study. J Am Coll Cardiol 2015; 66: 1747-1761. PMID: 26483097 111. Holman WL, Kormos RL, Naftel DC, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant 2009; 28: 44-50. PMID: 19134530 112. Adamson RM, Stahovich M, Chillcott S, et al. Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience. J Am Coll Cardiol 2011; 57: 2487-2495. PMID: 21679851 113. Feldman D, Pamboukian SV, Teuteberg JJ, et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 2013; 32: 157-187. PMID: 23352391 114. Clerkin KJ, Naka Y, Mancini DM, et al. The Impact of Obesity on Patients Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices. JACC Heart Fail 2016; 4: 761-768. PMID: 27614942 115. Yost G, Coyle L, Gallagher C, et al. The impact of extreme obesity on outcomes after left ventricular assist device implantation. J Thorac Dis 2017; 9: 4441-4446. PMID: 29268513 116. Raymond AL, Kfoury AG, Bishop CJ, et al. Obesity and left ventricular assist device driveline exit site infection. ASAIO J 2010; 56: 57- 60. PMID: 20051832 117. Akay MH, Nathan SS, Radovancevic R, et al. Obesity is associated with driveline infection of left ventricular assist devices. ASAIO J 2019; 65: 678-682. PMID: 30398982 118. Lindenfeld J, Feldman AM, Saxon L, et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation 2007; 115: 204-212. PMID: 17190867 119. Yoshioka D, Sakaguchi T, Saito S, et al. Initial experience of conversion of Toyobo paracorporeal left ventricular assist device to Dura- Heart left ventricular assist device. Circ J 2012; 76: 372-376. PMID: 22122967 120. Worku B, Pak SW, van Patten D, et al. The CentriMag ventricular assist device in acute heart failure refractory to medical management. J Heart Lung Transplant 2012; 31: 611-617. PMID: 22608770 121. Riggs KW, Fukushima S, Fujita T, et al. Mechanical support for patients with congenitally corrected transposition of the great arteries and end-stage ventricular dysfunction. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2019; 22: 66-73. PMID: 31027567 122. Michel E, Orozco Hernandez E, Enter D, et al. Bridge to transplantation with long-term mechanical assist devices in adults with transposition of the great arteries. Artif Organs 2019; 43: 90-96. PMID: 30129258 123. Peng DM, Koehl DA, Cantor RS, et al. Outcomes of children with congenital heart disease implanted with ventricular assist devices: An analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs). J Heart Lung Transplant 2019; 38: 420- 430. PMID: 30459063 124. Schumacher KR, Gossett J, Guleserian K, et al. Fontan-associated protein-losing enteropathy and heart transplant: A Pediatric Heart Transplant Study analysis. J Heart Lung Transplant 2015; 34: 1169- 1176. PMID: 25987313 125. Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail

2017; 19: 595-602. PMID: 28198133 126. Imamura T, Kinugawa K, Nitta D, et al. Prophylactic intra-aortic balloon pump before ventricular assist device implantation reduces perioperative medical expenses and improves postoperative clinical course in INTERMACS profile 2 patients. Circ J 2015; 79: 1963- 1969. PMID: 25971524 127. Kirklin JK, Naftel DC, Kormos RL, et al. Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant. J Heart Lung Transplant 2013; 32: 1205-1213. PMID: 24119728 128. Maltais S, Stulak JM. Right and left ventricular assist devices support and liver dysfunction: prognostic and therapeutic implications. Curr Opin Cardiol 2016; 31: 287-291. PMID: 27008370 129. Kirklin JK, Pagani FD, et al. Editors. American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. J Heart Lung Transplant 2020; 39: 187-219. PMID: 31983666 130. Yang JA, Kato TS, Shulman BP, et al. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant 2012; 31: 601-610. PMID: 22458997 131. Mikus E, Stepanenko A, Krabatsch T, et al. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipi-